MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Speech difficulties are linked to striatal dopaminergic deficits and cognitive decline in early de novo patients with Parkinson’s disease

    S. Polychronis, F. Niccolini, G. Pagano, M. Politis (London, United Kingdom)

    Objective: To investigate whether speech difficulties are associated with striatal dopaminergic deficits and whether are linked to progression of symptoms in early de novo patients…
  • 2017 International Congress

    Decreased Fronto-Parietal connection is associated with face pareidolia in Parkinson’s disease.

    Y. Kajiyama, M. Mihara, Y. Mitani, H. Otomune, H. Fujimoto, G. Revankar, K. Konaka, H. Mochizuki (Osaka, Japan)

    Objective: To investigate the neural mechanism of face pareidolia in Parkinson’s disease (PD) patients using resting state functional magnetic resonance imaging (rs-fMRI). Background: Face pareidolia…
  • 2017 International Congress

    Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson’s disease

    M. Gilat, P. Bell, K. Ehgoetz Martens, M. Georgiades, J. Hall, C. Walton, S. Lewis, J. Shine (Sydney, Australia)

    Objective: Investigating the role of dopaminergic medication on the neural mechanisms underlying lower limb motor automaticity during fMRI in 23 patients with PD that were…
  • 2017 International Congress

    The role of phosphodiesterase 4 in sleep disturbances in Parkinson’s disease

    H. Wilson, G. Pagano, F. Niccolini, N. Muhlert, C. Coello, M. Mehta, G. Searle, R. Gunn, E. Rabiner, T. Foltynie, M. Politis (London, United Kingdom)

    Objective: We aimed to assess the association between phosphodiesterase 4 (PDE4) expression and sleep disturbances in vivo using combined multimodal magnetic resonance imaging (MRI) and…
  • 2017 International Congress

    Clinical utility of visualization of Nigrosome-1 in patients with Parkinson’s disease

    A. Sunny, R. Naduthota, R. Botta, S. Varadharajan, J. Saini, R. Yadav, P. Pal (Bangalore, India)

    Objective: To determine the inter-rater reliability of Nigrosome-1 detection and its relation to asymmetry of clinical symptoms in Parkinson’s disease (PD).  Background: Detection of Nigrosome-1…
  • 2017 International Congress

    Syndenham’s chorea in Senegalese children: A case series

    F.S. NGOUNGOURE HALIMA, M. NDIAYE, A.D. SOW, B. SECK, M.M. NDIAYE (Dakar, Senegal)

    Objective: To describe clinical profile and treatment outcome of Sydenham’s chorea (SC) in children attending a tertiary care hospital in Dakar, Senegal. Background: SC is…
  • 2017 International Congress

    First Report of Clinical Outcomes Resulting from Use of Directional Deep Brain Stimulation in Parkinson’s Disease and Essential Tremor

    H. Braass, L. Venkatesan, C.-u. Choe, U. Hidding, B. Schönwald, C. Wargel, C. Buhmann, A. Gulberti, C. Moll, J. Köppen, C. Gerloff, W. Hamel, M. Pötter-Nerger (Hamburg, Germany)

    Objective: To evaluate clinical motor outcomes, the patient´s subjectively perceived benefit and the frequency of the use of directional lead stimulation in subjects with Essential tremor…
  • 2017 International Congress

    Tremor as the first symptom reported by Parkinson’s disease patients is a predictor of future motor subtype and levodopa-induced dyskinesia.

    A. Schumacher-Schuh, F. Drumond, J. Leal, M. Dotto, S. Machado, C. Rieder (Porto Alegre, Brazil)

    Objective: To better delineate risk profiles for the development of levodopa-induced dyskinesia is an important effort that can help understand this phenomenon and could impact…
  • 2017 International Congress

    MDS prodromal PD research criteria validation in two independent prospective cohorts

    A. Pilotto, S. Heinzel, U. Suenkel, S. Lerche, K. Brockmann, b. Roeben, E. Schaeffer, i. Wurster, R. Yilmaz, I. Liepelt-Scarfone, A. von Thaler, F. Metzger, g. Eschweiler, R. Postuma, W. Maetzler, D. Berg (Tuebingen, Germany)

    Objective: To evaluate the Movement Disorder Society prodromal Parkinson's disease criteria to two independent longitudinal studies Background: The MDS research criteria for prodromal Parkinson’s disease (PD)…
  • 2017 International Congress

    Dr. Paula Coutinho’s Seminal Contributions to the Understanding of Machado-Joseph’s Disease

    P. Marques, H. Teive, F. Germiniani, B. Garcia (Curitiba, Brazil)

    Objective: To recognize the contributions of Dr. Paula Coutinho to Neurology through her studies of Machado-Joseph’s disease (SCA3)  Background: One of the unique opportunities in…
  • « Previous Page
  • 1
  • …
  • 76
  • 77
  • 78
  • 79
  • 80
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25128 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley